עלינו

Pluri is pushing the boundaries of science and engineering to create cell-based products for commercial use and is pioneering a biotech revolution that promotes global wellbeing and sustainability. The Company’s technology platform, a patented and validated state-of-the-art 3D cell expansion system, advances novel cell-based solutions for a range of initiatives— from medicine and climate change to food scarcity, animal cruelty and beyond. Pluri’s method is uniquely accurate, scalable, cost-effective, and consistent from batch to batch. Pluri currently operates in the field of regenerative medicine and food-tech and aims to establish partnerships that leverage the company’s 3D cell-based technology to additional industries that require effective, mass cell production. To learn more, visit us at www.pluri-biotech.com or follow us on LinkedIn and Twitter.

אתר אינטרנט
http://www.pluri-biotech.com
תעשייה
Biotechnology Research
גודל החברה
51-200 עובדים
משרדים ראשיים
Haifa
סוג
חברה ציבורית
הקמה
2003
התמחויות

מיקומים

עובדים ב- Pluri

עדכונים

דפים דומים

מימון

Pluri 10 total rounds

סיבוב אחרון

לאחר ההנפקה הון עצמי

‏30,000,000.00 $

ראה מידע נוסף על crunchbase